On April 1, 2020, Medifron DBT Co., Ltd. (KOSDAQ:A065650) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,730 KRW | +4.92% | +2.05% | -24.65% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,520 KRW | -3.26% | -5.44% | 97.78M | ||
1,385 KRW | -0.14% | -0.22% | 84.38M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.65% | 146M | |
+16.87% | 70.43B | |
+6.14% | 17.32B | |
+14.28% | 13.86B | |
+10.80% | 12.84B | |
+11.68% | 9.65B | |
-18.93% | 6.57B | |
-8.38% | 5.77B | |
+1.96% | 5.16B | |
+1.91% | 5.07B |
- Stock Market
- Equities
- A204620 Stock
- News Global Tax Free Co., Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 10.999996728 billion in funding from Brain Contents CO., LTD., Swanicoco Co., Ltd., Global Tax Free Co., Ltd.